May 15, 2025) Discoveries announced today by St. Jude Children's Research Hospital provide a scientific rationale for the targeted ...

Discoveries announced today by St. Jude Children's Research Hospital provide a scientific rationale for the targeted ...

The nuclear pore complex protein RANBP2 has emerged as a critical factor in the development and progression of various solid malignancies.

The nuclear pore complex protein RANBP2 has emerged as a critical factor in the development and progression of various solid malignancies. As a SUMO ...

The nuclear pore complex protein RANBP2 has emerged as a critical factor in the development and progression of various solid ...

Their findings pave the ... Cancer Risk Linked to P53 in Ulcerative Colitis Oct. 25, 2024 — Researchers have elucidated the role of the p53 gene in ulcerative colitis. The study suggests a ...

The genomes of long-living, big-brained mammal species reveal that they carry more copies of immunity genes. Experts ...

Detailed price information for Sellas Life Sciences Group Inc (SLS-Q) from The Globe and Mail including charting and trades.

Work at Scorpion Therapeutics Inc. has led to the identification of cellular tumor antigen p53 (TP53) (Y220C mutant) activators reported to be useful for the treatment of cancer.

Sports investment could be set to buck economic headwinds, attorneys say, as minority stakes, emerging leagues and new media ...